These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12630676)

  • 1. A novel substance purified from Perilla frutescens Britton inhibits an early stage of HIV-1 replication without blocking viral adsorption.
    Kawahata T; Otake T; Mori H; Kojima Y; Oishi I; Oka S; Fukumori Y; Sano K
    Antivir Chem Chemother; 2002 Sep; 13(5):283-8. PubMed ID: 12630676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.
    Witvrouw M; Fikkert V; Pluymers W; Matthews B; Mardel K; Schols D; Raff J; Debyser Z; De Clercq E; Holan G; Pannecouque C
    Mol Pharmacol; 2000 Nov; 58(5):1100-8. PubMed ID: 11040059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-2(ROD) replication in a lymphoblastoid cell line by the alpha1-antitrypsin Portland variant (alpha1-PDX) and the decRVKRcmk peptide: comparison with HIV-1(LAI).
    Bahbouhi B; Bendjennat M; Chiva C; Kogan M; Albericio F; Giralt E; Seidah NG; Bahraoui E
    Microbes Infect; 2001 Nov; 3(13):1073-84. PubMed ID: 11709287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of human immunodeficiency virus replication by RD6-Y664, a novel benzylhydroxylamine derivative.
    Okamoto M; Fujiwara M; Kodama E; Yamamoto O; Shigeta S; Mitsuya H; Konno K; Yokota T; Baba M
    Antivir Chem Chemother; 1999 Mar; 10(2):71-7. PubMed ID: 10335401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro effects of AZT and extracts of Ocimum gratissimum, Ficus polita, Clausena anisata, Alchornea cordifolia, and Elaeophorbia drupifera against HIV-1 and HIV-2 infections.
    Ayisi NK; Nyadedzor C
    Antiviral Res; 2003 Mar; 58(1):25-33. PubMed ID: 12719004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of anti-human immunodeficiency virus action of polyoxometalates, a class of broad-spectrum antiviral agents.
    Yamamoto N; Schols D; De Clercq E; Debyser Z; Pauwels R; Balzarini J; Nakashima H; Baba M; Hosoya M; Snoeck R
    Mol Pharmacol; 1992 Dec; 42(6):1109-17. PubMed ID: 1282664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and characterization of niphatevirin, a human-immunodeficiency-virus-inhibitory glycoprotein from the marine sponge Niphates erecta.
    O'Keefe BR; Beutler JA; Cardellina JH; Gulakowski RJ; Krepps BL; McMahon JB; Sowder RC; Henderson LE; Pannell LK; Pomponi SA; Boyd MR
    Eur J Biochem; 1997 Apr; 245(1):47-53. PubMed ID: 9128723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isothiazole derivatives as novel HIV replication inhibitors.
    Cutrì CC; Garozzo A; Pannecouque C; Castro A; Guerrera F; De Clercq E
    Antivir Chem Chemother; 2004 Jul; 15(4):201-5. PubMed ID: 15457681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New targets for inhibitors of HIV-1 replication.
    Moore JP; Stevenson M
    Nat Rev Mol Cell Biol; 2000 Oct; 1(1):40-9. PubMed ID: 11413488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agents.
    Kucera LS; Iyer N; Morris-Natschke SL; Chen SY; Gumus F; Ishaq K; Herrmann DB
    Antivir Chem Chemother; 1998 Mar; 9(2):157-65. PubMed ID: 9875387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.
    Takashima K; Miyake H; Kanzaki N; Tagawa Y; Wang X; Sugihara Y; Iizawa Y; Baba M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3474-82. PubMed ID: 16048963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of diterpenes isolated from the Brazilian marine alga Dictyota menstrualis against human immunodeficiency virus type 1 (HIV-1).
    Pereira HS; Leão-Ferreira LR; Moussatché N; Teixeira VL; Cavalcanti DN; Costa LJ; Diaz R; Frugulhetti IC
    Antiviral Res; 2004 Oct; 64(1):69-76. PubMed ID: 15451181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.
    Lai JP; Ho WZ; Zhan GX; Yi Y; Collman RG; Douglas SD
    Proc Natl Acad Sci U S A; 2001 Mar; 98(7):3970-5. PubMed ID: 11274418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.
    Princen K; Hatse S; Vermeire K; Aquaro S; De Clercq E; Gerlach LO; Rosenkilde M; Schwartz TW; Skerlj R; Bridger G; Schols D
    J Virol; 2004 Dec; 78(23):12996-3006. PubMed ID: 15542651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxysterols, but not cholesterol, inhibit human immunodeficiency virus replication in vitro.
    Moog C; Aubertin AM; Kirn A; Luu B
    Antivir Chem Chemother; 1998 Nov; 9(6):491-6. PubMed ID: 9865387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic effect of NMSO3 on replication of human immunodeficiency virus.
    Nakamura M; Terada M; Kamada M; Yokono A; Nakamori S; Ohno T
    Antivir Chem Chemother; 2003 Jul; 14(4):171-6. PubMed ID: 14582845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle.
    Daelemans D; Dumont JM; Rosenwirth B; De Clercq E; Pannecouque C
    Antiviral Res; 2010 Feb; 85(2):418-21. PubMed ID: 19857522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.